Inogen paves way for new CFO
By HME News Staff
Updated 9:41 AM CST, Mon December 13, 2021
GOLETA, Calif. – Inogen has appointed Mike Sergesketter as interim CFO effective immediately, succeeding Alison Bauerlein, who will be staying with the company in a transitional role through the first quarter of 2022.
“The changes we have made to our executive team support our continued strategic evolution and our goal of transforming Inogen into a more prominent player in respiratory care,” said Nabil Shabshab, president and CEO. “I’m confident Mike’s strong experience in finance, strategic manufacturing and M&A, as well as his global perspective, will be a tremendous asset as we continue to execute against our plans. I am grateful for the time and collaboration I have had with Ali and want to thank her for her many contributions as a key member of the team that launched and grew Inogen. I wish her well in her future endeavors.”
Inogen has retained a leading executive search firm to help with the search for a permanent replacement.
Sergesketter most recently served as the CFO of Kimball Electronics, where he was instrumental in helping to develop and execute the company’s globalization strategy, while also building a robust finance function designed to support the company’s growth.
Comments